Simultaneous integrated boost therapy of carcinoma of the hypopharynx/larynx with and without flattening filter - a treatment planning and dosimetry study.

about

Second cancer risk after radiation therapy of ependymoma using the flattening filter free irradiation mode of a linear accelerator

P2860

Q58765974-690F4D73-FC9C-4349-880F-314C3AFE9498

P2860

Simultaneous integrated boost therapy of carcinoma of the hypopharynx/larynx with and without flattening filter - a treatment planning and dosimetry study.

Item

http://www.wikidata.org/entity/Q40954564

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Simultaneous integrated boost ...... planning and dosimetry study.

@en

type

Item

label

Simultaneous integrated boost ...... planning and dosimetry study.

@en

prefLabel

Simultaneous integrated boost ...... planning and dosimetry study.

@en

P1476

Simultaneous integrated boost ...... t planning and dosimetry study

@en

P2093

Amine Khemissi

http://www.w3.org/2001/XMLSchema#string

Matthias G Hautmann

http://www.w3.org/2001/XMLSchema#string

Oliver Koelbl

http://www.w3.org/2001/XMLSchema#string

Tina Obermeier

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

Solid cancer incidence in atomic bomb survivors: 1958-1998

Radiotherapy dose-volume effects on salivary gland function

Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22).

Differentiation of irradiation and cetuximab induced skin reactions in patients with locally advanced head and neck cancer undergoing radioimmunotherapy: the HICARE protocol (head and neck cancer: immunochemo and radiotherapy with erbitux) - a multi

Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments.

mARC Treatment of Hypopharynx Carcinoma with Flat and Flattening-Filter-Free Beam Energies - A Planning Study.

Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.

Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck.

Optimizing the flattening filter free beam selection in RapidArc®-based stereotactic body radiotherapy for Stage I lung cancer.

P2888

s13014-017-0850-8

P304

114

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13014-017-0850-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Barbara Dobler

P577

2017-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090388051

http://www.w3.org/2001/XMLSchema#string

P698

28679448

http://www.w3.org/2001/XMLSchema#string

P921

Bagtingan

P932

5499025

http://www.w3.org/2001/XMLSchema#string

Simultaneous integrated boost therapy of carcinoma of the hypopharynx/larynx with and without flattening filter - a treatment planning and dosimetry study.

about

P2860

P2860

Simultaneous integrated boost therapy of carcinoma of the hypopharynx/larynx with and without flattening filter - a treatment planning and dosimetry study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932